Wednesday, 29 July 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
Gland Pharma Receives US FDA Approval… ▲ Market News / Economy Renaissance Global Expands U.S. Retail Presence… ▲ Capex & Future Plans Shyam Metalics Commissions ₹150 Crore Beneficiation… ▲ Capex & Future Plans Vardhman Special Steels Highlights Strong Q1… ▲ Capex & Future Plans Magellanic Cloud Subsidiary Bags $1.21 Million… ▲ Order Book Manipal Health IPO 2026: Issue Details,… ▲ Ipos Car trade Tech Limited Partners With… ▲ Capex & Future Plans
Home / Company Results / TCS Q4 FY26 Performance Analysis: Steady Growth Amidst Margin Resilience
RS · Company Results

TCS Q4 FY26 Performance Analysis: Steady Growth Amidst Margin Resilience

TCS Quarterly Financial Report

TCS — Quarterly Financial Report

Data Updated As Of **Mar 2026** (March 2026)

Key Performance Indicators

Sales (Mar 2026)

₹70,698 Cr

Net Profit (Mar 2026)

₹13,784 Cr

EPS (Rs.)

37.92

OPM (%)

27.00

Performance Visualization (Financials limited to Last 5 Quarters)

Quarterly Snapshot : Figures in Rs. Crores

Metric Mar 2026 Dec 2025 Mar 2025
Sales (₹ Cr) 70,698 67,087 64,479
Operating Profit (₹ Cr) 19,276 18,269 16,980
Net Profit (₹ Cr) 13,784 10,720 12,293
EPS (Rs.) 37.92 29.45 33.79
OPM (%) 27.00 27.00 26.00

Executive Summary

In **Mar 2026**, TCS reported **sales** of ₹70,698 Cr. **Up** 5.4% quarter-over-quarter (QoQ). **Up** 9.6% year-over-year (YoY).

In **Mar 2026**, TCS reported **net profit** of ₹13,784 Cr. **Up** 28.6% quarter-over-quarter (QoQ). **Up** 12.1% year-over-year (YoY).

In **Mar 2026**, TCS reported **eps** of Rs. 37.92. **Up** 28.8% quarter-over-quarter (QoQ). **Up** 12.2% year-over-year (YoY).

In **Mar 2026**, TCS reported **operating margin** of 27.00%. **Down** 0.0% quarter-over-quarter (QoQ). **Up** 3.8% year-over-year (YoY).